Welcome back friends, today we will be discussing an FDA approved monoclonal antibody drug for asthma called omalizumab, or xolair. Now what is a “monoclonal antibody drug” and what does it do? Monoclonal antibodies are made by clones of immune cells and are only able to bind to one type of antigen. These antibodies are used often to treat diseases as they each target the specific antigens in the body produced due to the disease. As mentioned before, xolair is used to treat patients with asthma ages 12 or older. According to John Hopkins Medicine, this medication is used to decrease the number of asthma attacks that a patient experiences and has also shown to either reduce or eliminate other medications used for the same condition.
Side Effects
Xolair targets the antibodies in the blood stream, preventing them from binding to the surfaces of the mast cells and basophils. Because of this, the cells are unable to release their chemicals, therefore preventing the allergic reaction and/or inflammation. Like all medications, there are side effects associated with xolair, the most common side effects being: headaches, viral infections, upper respiratory tract infections, and injection-site reactions (such as pain, redness, swelling, etc.). The most serious side effects of xolair life-threatening allergic reactions, difficulty breathing (what a coincidence), fainting, low blood pressure, and swelling of the tongue or throat. According to Xolair, the manufacturer website, people considered high risk for a parasitic infection are more susceptible at getting a parasitic infection after receiving this medication.
Impact On Immune System
As the drug is directly working with part of the immune system to prevent asthma attacks, it suppresses the acquired immune response. The impacts of the drug on the immune system can be seen as both positive and negative based off of the list of side effects. While the drug is working to prevent the number of asthma attacks that a patient experiences, it is also negatively affecting the immune system and showing side effects in the patient. But just like all drugs working to prevent disease, one must weigh out the positives with the negatives to decide whether or not to go on with a treatment. Asthma is a disease that runs in my family, so I would definitely consider taking xolair if it were up to me. If one was to experience a side effect of the medication, they could easily consult a doctor on whether or not to continue on with the treatment.



